Press "Enter" to skip to content

GSK’s ViiV seeks marketing licence for baby-friendly HIV pill

About 1.7 million children have HIV, most of them in sub-Saharan Africa, the United Nations agency UNAIDS says. If approved by regulators, the medicine will be the first new generation HIV medicine available in baby-friendly form.

Original source: https://health.economictimes.indiatimes.com/news/pharma/gsks-viiv-seeks-marketing-licence-for-baby-friendly-hiv-pill/72529177?utm_source=RSS&utm_medium=ETRSS

Also Read:   Overweight, obese kids have higher asthma risk